Familial medullary thyroid carcinoma: Not a distinct entity? Genotype-phenotype correlation in a large family

This publication has 20 references indexed in Scilit:

• Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A
  Human Genetics, 1996
• Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
  Science, 1995
• Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
  Nature, 1994
• A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
  Nature, 1994
• Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
  Human Molecular Genetics, 1993
• Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
  Nature, 1993
• Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entity
  British Journal of Surgery, 1986
• STIMULATION OF THYROCALCITONIN SECRETION BY PENTAGASTRIN AND CALCIUM IN TWO PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID.
  Journal of Clinical Endocrinology & Metabolism, 1973
• Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid—a syndrome
  Cancer, 1968
• The association of pheochromocytoma with carcinoma of the thyroid gland
  The American Journal of Medicine, 1961